DOPE (18:1 PE)- 200mg powder and 1 more item

The University of Nebraska Medical Center (UNMC), a state institution in Nebraska, awarded a purchase order to Avanti Polar Lipids Inc., a Dallas, Texas-based vendor, for specialized biochemical materials. The contract, issued May 7, 2026, with delivery scheduled for May 11, 2026, is valued at $537.27 and comprises two line items: one unit of DOPE (Dioleoylphosphatidylethanolamine) 18:1 PE 200mg powder at $306.00 and one unit of 18:0 PC (dipalmitoylphosphatidylcholine) 1g at $231.27. The materials were directed to the UNMC General Supply department in Omaha, Nebraska.

The purchase order is governed by the University of Nebraska Standard Terms of Purchase and includes standard commercial provisions including Net 30 payment terms, F.O.B. destination with freight prepaid, and a requirement that the vendor acknowledge acceptance within ten days. UNMC's tax-exempt status (Tax Exempt #05-8905401) applies to the transaction. The vendor was required to reference the purchase order number on all packages, invoices, and related documentation, with all correspondence directed to UNMC Purchasing.